Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lung cancer
lung cancer
OS Therapies’s HER2 therapy prevents lung cancer recurrence in 33% patients
Clinical Trials Arena
Thu, 01/16/25 - 11:06 am
OS Therapies
lung cancer
HER2 Inhibitor
J&J says its lung cancer drug combination keeps people alive longer
CNBC
Tue, 01/7/25 - 11:13 am
JNJ
Rybrevant
Lazcluze
AstraZeneca
Tagrisso
clinical trials
lung cancer
Roche records setback in phase III study of two lung cancer drugs
MSN/Reuters
Tue, 11/26/24 - 11:17 am
Roche
anti-TIGIT
tiragolumab
Tecentriq
clnical trials
lung cancer
Roche’s tiragolumab flops in another Phase III lung cancer trial
Clinical Trials Arena
Tue, 11/26/24 - 09:53 am
Roche
tiragolumab
clinical trials
lung cancer
AstraZeneca, Daiichi withdraw lung cancer approval application for Enhertu follow-up and try again
Fierce Biotech
Tue, 11/12/24 - 08:44 pm
AstraZeneca
Daiichi Sankyo
lung cancer
FDA
Dato-DXd
Enhertu
IDEAYA reports Phase 1 expansion data for IDE397
MSN/Seeking Alpha
Sun, 10/27/24 - 07:45 pm
Ideaya
clinical trials
IDE397
MTAP
urothelial cancer
lung cancer
mRNA Covid-19 vaccines may boost cancer immunotherapy effectiveness
Clinical Trials Arena
Tue, 10/1/24 - 10:42 am
MRNA
vaccines
lung cancer
ESMO
COVID-19
TIGIT drug from iTeos shrinks lung tumors in trial
BioPharma Dive
Sun, 09/15/24 - 06:28 pm
ESMO
iTeos Therapeutics
Tigit
GSK
lung cancer
belrestotug
Merck stops phase 3 TIGIT trial in lung cancer for futility—and sees immune side effects again
Fierce Biotech
Thu, 08/8/24 - 11:04 am
Merck
Tigit
lung cancer
clinical trials
MK-7684A
Gilead’s Trodelvy stumbles in late-stage trials but remains prized cancer asset
BioSpace
Mon, 07/1/24 - 11:39 am
Gilead Sciences
Trodelvy
bladder cancer
lung cancer
clinical trials
ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation
Fierce Pharma
Mon, 06/3/24 - 12:10 pm
ASCO 2024
AstraZeneca
Tagrisso
Imfinzi
lung cancer
non-small cell lung cancer
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters
Fri, 05/31/24 - 10:44 am
Pfizer
Lorbrena
lung cancer
Novocure's lung cancer device slows progression to brain in trial, shares rise
Reuters
Wed, 03/27/24 - 10:51 am
Novocure
clinical trials
Medtech
lung cancer
tumor treating fields
non-small cell lung cancer
Iovance receives more good news as FDA lifts hold on lung cancer cell therapy trial
Fierce Biotech
Mon, 03/4/24 - 11:50 am
Iovance Biotherapeutics
FDA
LN-145
lung cancer
cell therapy
clinical trials
Roche evaluates options for its lung disease drug
Reuters
Mon, 02/26/24 - 05:12 pm
Roche
Esbriet
lung cancer
FDA approves AstraZeneca's Tagrisso-chemo combo
Reuters
Sun, 02/18/24 - 08:26 pm
AstraZeneca
Tagrisso
lung cancer
FDA
Gilead stops phase 3 TIGIT trial, doubling down on other studies and pumping $320M into partner Arcus
Fierce Biotech
Tue, 01/30/24 - 10:34 am
Gilead Sciences
Arcus Biosciences
Tigit
lung cancer
clinical trials
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff
Fierce Pharma
Mon, 01/22/24 - 11:21 am
Gilead Sciences
antibody-drug conjugate
Trodelvy
lung cancer
clinical trials
AbbVie-backed Disco gets down with €20M to find new targets for antibody-based therapies
Fierce Biotech
Tue, 01/16/24 - 09:14 am
Disco Pharmaceuticals
AbbVie
venture capital
lung cancer
colorectal cancer
AstraZeneca picks up a friend for Tagrisso in $40M upfront deal
Fierce Biotech
Tue, 01/2/24 - 10:05 pm
AstraZeneca
Allorion Therapeutics
lung cancer
Tagrisso
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »